MyFinsight
Home
Blog
About
Back
Income Statement
Protalix BioTherapeutics, Inc. (PLX)
Protalix BioTherapeutics, Inc. (PLX)
source: myfinsight.com
Chiesi
$14,035K
(43.32%↑ Y/Y)
Pfizer
$4,279K
(-24.23%↓ Y/Y)
Fiocruz
$1,514K
Product
$19,828K
(28.42%↑ Y/Y)
License And Service
$68K
(-68.81%↓ Y/Y)
Total revenue
$19,896K
(27.07%↑ Y/Y)
Financial income
$682K
(150.74%↑ Y/Y)
Operating income (loss)
$4,672K
(298.63%↑ Y/Y)
Financial income
(expenses), net
$188K
(136.79%↑ Y/Y)
Cost of revenues
$7,762K
(32.23%↑ Y/Y)
Research and development
expenses, net
$4,351K
(-27.39%↓ Y/Y)
Selling, general, and
administrative expenses
$3,111K
(18.56%↑ Y/Y)
Financial expenses
$494K
(-36.91%↓ Y/Y)
Income (loss) before
taxes on income
$4,860K
(635.25%↑ Y/Y)
Net income (loss)
$3,777K
(2203.05%↑ Y/Y)
Taxes on income
$1,083K
(117.91%↑ Y/Y)
Back